Religion and Ethics Forum

General Category => Politics & Current Affairs => Topic started by: Nearly Sane on March 03, 2023, 08:56:17 AM

Title: Half of world on track to be overweight by 2035
Post by: Nearly Sane on March 03, 2023, 08:56:17 AM

Headline makes it sound like an achievement.

https://www.bbc.co.uk/news/world-64831848
Title: Re: Half of world on track to be overweight by 2035
Post by: Udayana on March 03, 2023, 12:55:28 PM
Clearly we need more drugs!

New drugs could spell an end to the world’s obesity epidemic  (https://archive.vn/xp5eL)

Quote
A new type of drug is generating excitement among the rich and the beautiful. Just a jab a week, and the weight falls off. Elon Musk swears by it; influencers sing its praises on TikTok; suddenly slimmer Hollywood starlets deny they have taken it. But the latest weight-loss drugs are no mere cosmetic enhancements. Their biggest beneficiaries will be not celebrities in Los Angeles or Miami but billions of ordinary people around the world whose weight has made them unhealthy.
...
Title: Re: Half of world on track to be overweight by 2035
Post by: Nearly Sane on March 03, 2023, 01:01:11 PM
Clearly we need more drugs!

New drugs could spell an end to the world’s obesity epidemic  (https://archive.vn/xp5eL)
Wow! That's the puffiest of puff pieces. I feel stuffed just reading it.
Title: Re: Half of world on track to be overweight by 2035
Post by: Udayana on March 03, 2023, 01:25:09 PM
Yeah, there seems to be bubble growing behind this class of drug - and for issues other than diabetes and obesity too.
Title: Re: Half of world on track to be overweight by 2035
Post by: Udayana on March 12, 2023, 11:41:37 AM
Update:

https://www.theguardian.com/business/2023/mar/12/revealed-experts-who-praised-new-skinny-jab-received-payments-from-drug-maker

Quote
The drug giant behind weight loss injections newly approved for NHS use spent millions in just three years on an “orchestrated PR campaign” to boost its UK influence.

As part of its strategy, Novo Nordisk paid £21.7m to health organisations and professionals who in some cases went on to praise the treatment without always making clear their links to the firm, an Observer investigation has found.